Liontrust Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Buy |
702,386
+107,331
| +18% | +$543K | 0.05% | 136 |
|
|
2025
Q1 | $3.15M | Sell |
595,055
-336,672
| -36% | -$1.78M | 0.05% | 137 |
|
|
2024
Q4 | $6.3M | Sell |
931,727
-58,273
| -6% | -$394K | 0.09% | 115 |
|
|
2024
Q3 | $7.43M | Hold |
990,000
| – | – | 0.11% | 107 |
|
|
2024
Q2 | $7.43M | Buy |
990,000
+240,000
| +32% | +$1.8M | 0.11% | 107 |
|
|
2024
Q1 | $7.48M | Buy |
750,000
+235,000
| +46% | +$2.34M | 0.1% | 110 |
|
|
2023
Q4 | $5.08M | Sell |
515,000
-5,000
| -1% | -$49.3K | 0.07% | 120 |
|
|
2023
Q3 | $3.98M | Buy |
+520,000
| New | +$3.98M | 0.06% | 122 |
|